Drug Discovery

© Getty Images

Adcendo raises $34 million to fund ADC treatments for sarcoma

By Jonathan Smith


The Danish biotech Adcendo has bagged a Series A extension round of €31 million ($33.8 million), taking its Series A winnings so far to €82 million ($89.5 million). The round will bankroll the development of Adcendo’s pipeline of antibody-drug...

Pic:getty/kojofeja

BigHat Biosciences enters AI research collaboration with Merck

By Rachel Arthur

BigHat Biosciences, a US biotech with a machine learning-guided antibody discovery and development platform, has announced a collaboration with Merck to apply its technology to design candidates for up to three drug discovery programs.

© GettyImages/kingwin

NPD Gallery: Technology Insider

By Jane Byrne

What's new in the world of biopharmaceutical tech this month? We track developments in process innovation equipment.

M&A, partnerships and new services in pharma outsourcing

New pharma services from M&A and partnerships: round-up

By Natalie Morrison

Outsourcing-Pharma.com presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and Accenture’s new...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All